Skip to main content

Animations

MJFF Publications

7121 - 7130 of 9033 Results
Title
Year
  • Year
  • 2019
  • 2020
  • 2025
  • 2022
  • 2023
  • 2025
  • 2023
  • 2024
  • 2016
  • 2020
  • Summary Details
    OPEN
    Title: Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-019-0556-3
    Citation Count: 181
  • Summary Details
    OPEN
    Title: Quantitative Measurements of LRRK2 in Human Cerebrospinal Fluid Demonstrates Increased Levels in G2019S Patients
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2020.00526
    Citation Count: 34
  • Summary Details
    OPEN
    Title: The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-025-03834-0
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemic
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.049755
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A blood-based marker of mitochondrial DNA damage in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abo1557
    Citation Count: 80
  • Summary Details
    OPEN
    Title: Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf379
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Genome‐Wide Analysis of Structural Variants in Parkinson Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26608
    Citation Count: 37
  • Summary Details
    OPEN
    Title: A machine learning contest enhances automated freezing of gait detection and reveals time-of-day effects
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49027-0
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’S
    Journal Name: Personalized Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2217/pme-2016-0087
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort Experience
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-191901
    Citation Count: 61
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.